ArticleCancers2021

A Growth Modulation Index-Based GEISTRA Score as a New Prognostic Tool for Trabectedin Efficacy in Patients with Advanced Soft Tissue Sarcomas: A Spanish Group for Sarcoma Research (GEIS) Retrospective Study.

Javier Martínez-Trufero et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.